Cannabis Flashcards
emergent view
only one lineage
produces cannabis phytocannabinoid chemotypes
e.g. TCH and CBD + others
experience is chemical-dependent
cultivars
‘strains’
sativa
indica
ruderalis
synthesis
phytocannabinoids, terpenes, etc. are synthesized in heads = produced in trichomes
cannabis extraction
solvent or solvent-less
super-critical
goal: high purity or a single isolated compound
forms of cannabis
flower
pre-rolls
extracts
oil
soft gels
topicals
vapes
beverages
edibles
calculation of THC%
% is mg per g (1/1000)
15% = 150mg / 1g = 150/1000mg = 0.15
THC vs total THC (THC + THCA) per unit
chemical composition
psychoactive, non-psychoactive, synthetic
most are in acid forms in plant
THC acid; CBD acid
THC acid
psychoactive
CBD acid
anti oxidant
anti convulsant
anti inflammatory
anti anxiety
anti psychotic
neuro protective
CBG + THCV
CBG: precursor to other cannabinoids; individual effects in vitro
THCV: ‘metabolic reset’ - Ozempic
cultivar selection
personalize
tailor therapeutic effect to the disease + individual
medical cannabinoid
only CBD
administration
to optimize absorption: THCA → THC by heat or pressure (decarboxylation)
inhalation, ingestion, oral - sublingual, topical
smoke
solid/liquid particulates and gases created during combustion
similar levels of tar, CO, acetaldehyde, etc. as seen in cigarettes
poorer filtration of cannabis = more irritation
risks of inhalation
increased risk of chronic cough, bronchitis
no link to lung cancer or COPD
combustion/pyrolysis generates carcinogens (O2 + high temp)
ingestion
slower onset of effect
less predictability of action
more user control
distribution
THC is fat-soluble (lipophilic) → easily crosses BBB
brain, liver
peak effects 15-60 min
TI > 1000
metabolism
CYP450 system - liver
long half-lives
duration: 2-12 hrs
metabolites can stay in body for days or weeks
first pass metabolite - 11-hydroxy-9-THC
absorption - inhalation
10-15 sec onset
22% bioavailability
absorption - ingestion
45-60 min onset
10% bioavailability
absorption - oral
20-45 min onset
excretion
kidney
endogenous CBR ligands
arachidonoyl ethanolamide (AEA)
2-arachidonoylglycerol (2-AG)
CB1 receptors
expressed in CNS, eye, pancreas, liver, skin, uterus, testes
= widely
Gi/o linked